Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer
NCT01763450
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Liver Metastases
Colorectal Cancer
Interventions
DRUG:
bevacizumab plus chemotherapy
Sponsor
Liaoning Cancer Hospital & Institute